Ventricular assist devices are mechanical pumps used to support cardiac circulation in patients who have weakened hearts.

A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The function of VADs is different from that of artificial cardiac pacemakers; some are for short-term use, typically for patients recovering from myocardial infarction (heart attack) and for patients recovering from cardiac surgery; some are for long-term use (months to years to perpetuity), typically for patients suffering from advanced heart failure.
In United States, Ventricular Assist Device key players include AbioMed, Abbott (Thoratec), Medtronic (HeartWare), etc. United States top five manufacturers hold a share over 95%.
In terms of product, LVADs is the largest segment, with a share about 90%. And in terms of application, the largest application is Bridge-to-transplant (BTT) , followed by Destination Therapy (DT).

Market Analysis and Insights: Global and United States Ventricular Assist Device Market
This report focuses on global and United States Ventricular Assist Device market.
In 2020, the global Ventricular Assist Device market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the Ventricular Assist Device market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Ventricular Assist Device Scope and Market Size
Ventricular Assist Device market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Ventricular Assist Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Ventricular Assist Device market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
LVADs
RVADs
BIVADs

Segment by Application
Bridge-to-transplant (BTT)
Destination Therapy (DT)
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
AbioMed
Abbott (Thoratec)
Medtronic (HeartWare)
Berlin Heart